IonQ Announces Fourth Quarter and Full Year 2025 Financial Results
Key Terms
gaap financial
adjusted ebitda financial
adjusted eps financial
non-gaap financial measures financial
warrant liabilities financial
Achieves
-
Reported
of Annual Revenue, Representing$130.0 Million 202% Year-Over-Year Growth, Fueled by Organic Growth and Commercial Traction - Beats Guidance for Both Top and Bottom Line
-
First Quantum Company with More Than
of Annual GAAP Revenue$100 Million -
Announced Agreement to Acquire SkyWater Technology, Creating Well Capitalized Merchant Supplier for Entire
U.S. Quantum Industry -
Expanded Agreement with QuantumBasel to Over
, Spanning Four Years and Four Generations of IonQ Systems$60 Million - Sold Fifth-Generation, 100-Qubit System to KISTI, Anchoring the Country’s Largest Quantum-Classical Compute Platform and Positioning Hybrid AI, HPC, and NVIDIA Acceleration at the Core of Korea’s Next-Generation Compute Strategy
- Scaled to Become the World’s First Full-Stack Quantum Platform Company – Leading in Quantum Computing, Quantum Networking, Quantum Sensing, Quantum Security, and Quantum Merchant Supply
-
Cash, Cash Equivalents, and Investments as of December 31, 2025 of
$3.3 Billion
“I am pleased to share that IonQ has once again significantly outperformed our revenue guidance range, exceeding the midpoint by
“2025 was a year of tremendous accomplishments and both a strategic and financial inflection point for IonQ. We became the first public quantum company in history with more than
De Masi continued, “We announced an agreement to acquire SkyWater Technology, the world’s leading quantum chip foundry, to create the best capitalized and largest quantum merchant supplier in the world. SkyWater helps us build an IonQ platform that customers—especially government and other mission-driven buyers—can trust and plan around irrespective of geopolitics. Together, we intend to ensure the entire
Inder Singh, CFO and COO, added that “2025 represented historic growth for the company, and our results exceeded our own expectations for both top line and bottom line, as well as consensus estimates. In our 2025 revenues of
Fourth Quarter and Full Year 2025 Financial Highlights
-
Recognized revenue of
for the fourth quarter, which is$61.9 million 55% above the midpoint of the implied range and represents429% year-over-year growth -
Recognized revenue of
for the full year, which is$130.0 million 20% above the midpoint of the previously provided range and represents202% year-over-year growth -
Cash, cash equivalents, and investments were
as of December 31, 2025$3.3 billion -
Net income was
and GAAP EPS was$753.7 million for the fourth quarter. For the full year 2025, net loss was$2.13 ( and GAAP EPS was ($510.4) million )$1.82 -
Adjusted EBITDA loss was
( for the fourth quarter, and$67.4) million ( for the full year*$186.8) million -
Adjusted EPS was (
) for the fourth quarter and ($0.20 ) for the full year*$0.60
*Adjusted EBITDA and Adjusted EPS are non-GAAP financial measures defined under “Non-GAAP Financial Measures,” below, and are reconciled to net loss and GAAP EPS, the closest comparable GAAP measures, respectively, at the end of this release.
Fourth Quarter and Recent Business Highlights
-
Expanded Agreement with QuantumBasel to Over
, Spanning Four Years and Four Generations of IonQ Systems$60 Million - Sold Fifth-Generation, 100-Qubit System to KISTI, Anchoring the Country’s Largest Quantum-Classical Compute Platform and Positioning Hybrid AI, HPC, and NVIDIA Acceleration at the Core of Korea’s Next-Generation Compute Strategy
- Continued Innovation in Quantum-Enabled Life Sciences via Strategic Collaboration with CCRM to Accelerate Development of Advanced Therapeutics
-
Deployed Large-Scale, Operational, National Quantum Networks in
Switzerland ,Slovakia andRomania - Selected by DARPA for Phase B of the Quantum Benchmarking Initiative, Reflecting IonQ’s Demonstrated Quantum Capabilities
2026 Financial Outlook
-
For the full year 2026, IonQ expects revenue to be between
and$225 million , with between$245 million and$48 million for the first quarter$51 million -
For the full year 2026, IonQ anticipates an Adjusted EBITDA loss of between
( and$330) million ( *$310) million
*Adjusted EBITDA is a non-GAAP financial measure defined under “Non-GAAP Financial Measures,” below. The Company is unable to provide a reconciliation of forward-looking Adjusted EBITDA without unreasonable effort because of the uncertainty and potential variability in amount and timing of certain charges, including the change in the fair value of warrant liabilities, which are reconciling items between GAAP net income (loss) and Adjusted EBITDA and could significantly impact GAAP results.
Fourth Quarter and Full Year 2025 Conference Call
IonQ will host a conference call at 4:30 p.m. Eastern time today to discuss its results for the fourth quarter ended December 31, 2025 and to provide a business update. The call will be accessible by telephone at 1-888-349-0106 (domestic) or 1-412-902-0131 (international). The call will also be available live via webcast on the company’s website here, or directly here. A telephone replay of the conference call will be available approximately three hours after its conclusion at 1-855-669-9658 (domestic) or +1-412-317-0088 (international) with access code 3269425 and will be available until 11:59 PM Eastern time, March 11, 2026. An archive of the webcast will also be available here shortly after the call and will remain available for one year.
Upcoming Q1 2026 Conference Participation
- IonQ to participate in the Morgan Stanley Technology, Media & Telecom Conference taking place on Wednesday March 4, 2026. A webcast link to the fireside chat will be available on our investor relations website.
- IonQ to participate in the Cantor Global Technology & Industrial Growth Conference, taking place on Wednesday March 11, 2026. A webcast link will be available on our investor relations website.
Non-GAAP Financial Measures
To supplement IonQ’s condensed consolidated financial statements presented in accordance with GAAP, IonQ uses non-GAAP measures of certain components of financial performance. Adjusted EBITDA and Adjusted EPS are financial measures that are not required by or presented in accordance with GAAP. Management believes that these measures provide investors additional meaningful methods to evaluate certain aspects of the Company’s results period over period.
Adjusted EBITDA is defined as net loss attributable to IonQ, Inc. before net loss attributable to noncontrolling interests, interest income, interest expense, income tax (benefit) expense, depreciation and amortization, stock-based compensation, executive cash-based severance, change in fair value of warrant liabilities, offering costs associated with warrants and acquisition transaction and integration costs. Adjusted EPS is defined as earnings per share, or EPS, excluding the impact of stock-based compensation, executive cash-based severance, change in fair value of warrant liabilities, offering costs associated with warrants and acquisition transaction and integration costs. IonQ uses Adjusted EBITDA and Adjusted EPS to measure the operating performance of its business, excluding specifically identified items that it does not believe directly reflect its core operations and that may not be indicative of recurring operations.
The presentation of these non-GAAP financial measures is not meant to be considered in isolation or as a substitute for the financial results prepared in accordance with GAAP, and IonQ’s non-GAAP measures may be different from non-GAAP measures used by other companies. IonQ shows a reconciliation of its non-GAAP measures to the most directly comparable GAAP measures at the end of this release.
About IonQ
IonQ, Inc. [NYSE: IONQ] is the world’s leading quantum platform and merchant supplier - delivering integrated quantum solutions across computing, networking, sensing, and security. IonQ’s newest generation of quantum computers, the forthcoming IonQ Tempo, will be the latest in a line of cutting-edge systems that have been helping customers and partners including Amazon Web Services, AstraZeneca, and NVIDIA achieve 20x performance results and accelerate innovation in drug discovery, materials science, financial modeling, logistics, cybersecurity, and defense. In 2025, the company achieved
Headquartered in
Note to Investors Regarding Forward-Looking Statements
This press release contains forward-looking statements. All statements contained in this press release other than statements of historical fact are forward-looking statements, including statements regarding our guidance as to future financial and operational results, and the expected timing of the closing of our planned acquisition of SkyWater Technology, Inc., or SkyWater. In some cases, you can identify these statements by forward-looking words such as “pending,” “look forward,” “accelerate,” “anticipate,” “expect,” “suggest,” “plan,” “believe,” “intend,” “estimate,” “target,” “project,” “should,” “could,” “would,” “may,” “will,” “forecast,” “confident,” “position” and other similar expressions. These statements are only predictions based on our expectations and projections about future events as of the date of this press release and are subject to a number of risks, uncertainties and assumptions that may prove incorrect, any of which could cause actual results to differ materially from those expressed or implied by such statements, including, among others, those described under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the Securities and Exchange Commission. New risks emerge from time to time, and it is not possible for our management to predict all risks, nor can management assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statement we make. Investors are cautioned not to place undue reliance on any such forward-looking statements, which speak only as of the date they are made. Except as otherwise required by law, we undertake no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.
Notes on SkyWater Technology, Inc.
The financial results and outlook disclosed in this press release do not reflect the impact of the pending acquisition of SkyWater, which was announced on January 26, 2026. The transaction is expected to close in the second or third quarter of 2026, subject to approval by SkyWater shareholders, receipt of required regulatory approvals and satisfaction of other customary closing conditions.
Important Information and Where to Find It
In connection with the pending acquisition (the “Merger”) of SkyWater by IonQ, Inc. (the “Company”), the Company intends to file with the Securities and Exchange Commission (the “SEC”) a Registration Statement on Form S-4, which will include a prospectus with respect to the shares of Company common stock to be issued in the Merger and a proxy statement for SkyWater’s stockholders (the “Proxy Statement/Prospectus”), and SkyWater intends to file with the SEC the proxy statement. The definitive proxy statement (if and when available following the effectiveness of the Registration Statement) will be mailed to stockholders of SkyWater. Each of the Company and SkyWater may also file with or furnish to the SEC other relevant documents regarding the Merger. This communication is not a substitute for the Registration Statement, the Proxy Statement/Prospectus or any other document that the Company or SkyWater may file with the SEC or mail to SkyWater’s stockholders in connection with the Merger. INVESTORS AND SECURITY HOLDERS OF THE COMPANY AND SKYWATER ARE URGED TO READ THE REGISTRATION STATEMENT AND THE PROXY STATEMENT/PROSPECTUS INCLUDED WITHIN THE REGISTRATION STATEMENT WHEN THEY BECOME AVAILABLE, AS WELL AS ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC IN CONNECTION WITH THE MERGER OR INCORPORATED BY REFERENCE INTO THE REGISTRATION STATEMENT AND THE PROXY STATEMENT/PROSPECTUS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO), BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION REGARDING THE COMPANY, SKYWATER, THE MERGER AND RELATED MATTERS. The documents filed by the Company with the SEC also may be obtained free of charge at the Company’s website at investors.ionq.com. The documents filed by SkyWater with the SEC also may be obtained free of charge at SkyWater’s website at ir.skywatertechnology.com.
Participants in the Solicitation
The Company, SkyWater and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from the stockholders of SkyWater in connection with the Merger under the rules of the SEC. Information about the interests of the directors and executive officers of the Company and SkyWater and other persons who may be deemed to be participants in the solicitation of stockholders of SkyWater in connection with the Merger and a description of their direct and indirect interests, by security holdings or otherwise, will be included in the Proxy Statement/Prospectus, which will be filed with the SEC. Information about SkyWater’s directors and executive officers is set forth in SkyWater’s proxy statement for its 2025 Annual Meeting of Stockholders on Schedule 14A filed with the SEC on April 8, 2025, SkyWater’s Annual Report on Form 10-K for the year ended December 29, 2024 and any subsequent filings with the SEC. Information about certain of the Company’s directors and executive officers is set forth in the Company’s proxy statement for its 2025 Annual Meeting of Stockholders on Schedule 14A filed with the SEC on April 28, 2025 and any subsequent filings with the SEC. Additional information regarding the direct and indirect interests of those persons and other persons who may be deemed participants in the Merger may be obtained by reading the Proxy Statement/Prospectus regarding the Merger when it becomes available. Free copies of these documents may be obtained as described above.
No Offer or Solicitation
This communication is for informational purposes only and does not constitute, or form a part of, an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and otherwise in accordance with applicable law.
IonQ, Inc. Condensed Consolidated Statements of Operations (unaudited) (in thousands, except share and per share data) |
||||||||||||||||
Three Months Ended December 31, |
|
Year Ended December 31, |
||||||||||||||
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
||
| Revenue | $ |
61,890 |
|
$ |
11,710 |
|
$ |
130,016 |
|
$ |
43,073 |
|
||||
| Costs and expenses: | ||||||||||||||||
| Cost of revenue (excluding depreciation and amortization) |
|
43,593 |
|
|
5,045 |
|
|
77,488 |
|
|
20,597 |
|
||||
| Research and development |
|
96,095 |
|
|
40,077 |
|
|
305,705 |
|
|
136,827 |
|
||||
| Sales and marketing |
|
19,519 |
|
|
8,927 |
|
|
53,447 |
|
|
28,395 |
|
||||
| General and administrative |
|
90,669 |
|
|
29,660 |
|
|
245,087 |
|
|
71,055 |
|
||||
| Depreciation and amortization |
|
40,645 |
|
|
5,504 |
|
|
82,004 |
|
|
18,654 |
|
||||
| Total operating costs and expenses |
|
290,521 |
|
|
89,213 |
|
|
763,731 |
|
|
275,528 |
|
||||
| Loss from operations |
|
(228,631 |
) |
|
(77,503 |
) |
|
(633,715 |
) |
|
(232,455 |
) |
||||
| Gain (loss) on change in fair value of warrant liabilities |
|
949,640 |
|
|
(128,505 |
) |
|
66,710 |
|
|
(117,107 |
) |
||||
| Interest income, net |
|
29,528 |
|
|
4,141 |
|
|
55,997 |
|
|
18,249 |
|
||||
| Offering costs associated with warrants |
|
(22,867 |
) |
|
— |
|
|
(45,714 |
) |
|
— |
|
||||
| Other income (expense), net |
|
726 |
|
|
(111 |
) |
|
29 |
|
|
(275 |
) |
||||
| Income (loss) before income tax expense |
|
728,396 |
|
|
(201,978 |
) |
|
(556,693 |
) |
|
(331,588 |
) |
||||
| Income tax benefit (expense) |
|
24,877 |
|
|
(20 |
) |
|
44,572 |
|
|
(59 |
) |
||||
| Net income (loss) | $ |
753,273 |
|
$ |
(201,998 |
) |
$ |
(512,121 |
) |
$ |
(331,647 |
) |
||||
| Net income (loss) attributable to noncontrolling interests |
|
(394 |
) |
|
— |
|
|
(1,743 |
) |
|
— |
|
||||
| Net income (loss) attributable to IonQ, Inc. | $ |
753,667 |
|
$ |
(201,998 |
) |
$ |
(510,378 |
) |
$ |
(331,647 |
) |
||||
| Net income (loss) per share attributable to IonQ, Inc. common stockholders | ||||||||||||||||
| Basic | $ |
2.13 |
|
$ |
(0.93 |
) |
$ |
(1.82 |
) |
$ |
(1.56 |
) |
||||
| Diluted | $ |
1.93 |
|
$ |
(0.93 |
) |
$ |
(1.82 |
) |
$ |
(1.56 |
) |
||||
| Weighted average shares used in computing net income (loss) per share attributable to IonQ, Inc. common stockholders | ||||||||||||||||
| Basic |
|
345,739,278 |
|
|
217,947,427 |
|
|
280,345,046 |
|
|
213,029,365 |
|
||||
| Diluted |
|
368,982,917 |
|
|
217,947,427 |
|
|
280,345,046 |
|
|
213,029,365 |
|
||||
IonQ, Inc. Condensed Consolidated Balance Sheets (unaudited) (in thousands) |
||||||||
December 31, |
|
December 31, |
||||||
|
2025 |
|
|
|
2024 |
|
||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ |
1,030,865 |
|
$ |
54,393 |
|
||
| Short-term investments |
|
1,361,291 |
|
|
285,896 |
|
||
| Accounts receivable, net |
|
66,532 |
|
|
10,188 |
|
||
| Prepaid expenses and other current assets |
|
127,751 |
|
|
28,325 |
|
||
| Total current assets |
|
2,586,439 |
|
|
378,802 |
|
||
| Long-term investments |
|
944,643 |
|
|
23,545 |
|
||
| Property and equipment, net |
|
120,145 |
|
|
52,761 |
|
||
| Operating lease right-of-use assets |
|
22,724 |
|
|
9,470 |
|
||
| Intangible assets, net |
|
767,432 |
|
|
29,469 |
|
||
| Goodwill |
|
1,963,584 |
|
|
9,904 |
|
||
| Other noncurrent assets |
|
165,391 |
|
|
4,437 |
|
||
| Total Assets | $ |
6,570,358 |
|
$ |
508,388 |
|
||
| Liabilities and Stockholders’ Equity | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ |
26,138 |
|
$ |
5,230 |
|
||
| Accrued expenses and other current liabilities |
|
89,721 |
|
|
16,811 |
|
||
| Current portion of operating lease liabilities |
|
8,850 |
|
|
3,366 |
|
||
| Unearned revenue |
|
42,116 |
|
|
10,678 |
|
||
| Total current liabilities |
|
166,825 |
|
|
36,085 |
|
||
| Operating lease liabilities, net of current portion |
|
21,171 |
|
|
14,359 |
|
||
| Unearned revenue, net of current portion |
|
1,921 |
|
|
— |
|
||
| Warrant liabilities |
|
2,471,577 |
|
|
70,688 |
|
||
| Other noncurrent liabilities |
|
95,172 |
|
|
3,394 |
|
||
| Total liabilities | $ |
2,756,666 |
|
$ |
124,526 |
|
||
| Stockholders’ Equity: | ||||||||
| Common stock | $ |
36 |
|
$ |
22 |
|
||
| Additional paid-in capital |
|
5,006,250 |
|
|
1,067,403 |
|
||
| Accumulated deficit |
|
(1,194,098 |
) |
|
(683,720 |
) |
||
| Accumulated other comprehensive income (loss) |
|
(12,671 |
) |
|
157 |
|
||
| Total IonQ, Inc. stockholders' equity |
|
3,799,517 |
|
|
383,862 |
|
||
| Noncontrolling interests |
|
14,175 |
|
|
— |
|
||
| Total stockholders’ equity |
|
3,813,692 |
|
|
383,862 |
|
||
| Total Liabilities and Stockholders’ Equity | $ |
6,570,358 |
|
$ |
508,388 |
|
||
| IonQ, Inc.
Condensed Consolidated Statements of Cash Flows (unaudited) (in thousands) |
||||||||
Year Ended December 31, |
||||||||
|
2025 |
|
|
|
2024 |
|
||
| Cash flows from operating activities: | ||||||||
| Net loss | $ |
(512,121 |
) |
$ |
(331,647 |
) |
||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Depreciation and amortization |
|
82,004 |
|
|
18,654 |
|
||
| Stock-based compensation |
|
312,032 |
|
|
106,878 |
|
||
| (Gain) loss on change in fair value of warrant liabilities |
|
(66,710 |
) |
|
117,107 |
|
||
| Offering costs associated with warrants |
|
45,714 |
|
|
— |
|
||
| Deferred income taxes |
|
(44,868 |
) |
|
— |
|
||
| Amortization of premiums and accretion of discounts on available-for-sale securities |
|
(8,323 |
) |
|
(8,804 |
) |
||
| Other, net |
|
18,366 |
|
|
5,323 |
|
||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable |
|
(37,667 |
) |
|
1,609 |
|
||
| Prepaid expenses and other current assets |
|
(72,171 |
) |
|
(15,200 |
) |
||
| Accounts payable |
|
(7,636 |
) |
|
(601 |
) |
||
| Accrued expenses and other current liabilities |
|
7,382 |
|
|
(411 |
) |
||
| Unearned revenue |
|
9,285 |
|
|
(1,752 |
) |
||
| Other assets and liabilities |
|
(8,474 |
) |
|
3,161 |
|
||
| Net cash provided by (used in) operating activities | $ |
(283,187 |
) |
$ |
(105,683 |
) |
||
| Cash flows from investing activities: | ||||||||
| Purchases of property and equipment |
|
(16,417 |
) |
|
(17,992 |
) |
||
| Purchases of available-for-sale securities |
|
(2,669,300 |
) |
|
(296,329 |
) |
||
| Maturities of available-for-sale securities |
|
682,830 |
|
|
418,082 |
|
||
| Purchases of privately-held securities |
|
(88,500 |
) |
|
— |
|
||
| Businesses acquired, net of cash paid and acquired |
|
523 |
|
|
(15,454 |
) |
||
| Other investing, net |
|
(4,224 |
) |
|
(5,577 |
) |
||
| Net cash provided by (used in) investing activities | $ |
(2,095,088 |
) |
$ |
82,730 |
|
||
| Cash flows from financing activities: | ||||||||
| Proceeds from common stock and warrant issuance, net of issuance costs |
|
3,312,541 |
|
|
— |
|
||
| Proceeds from stock options exercised |
|
26,744 |
|
|
8,012 |
|
||
| Proceeds from warrants exercised |
|
11,436 |
|
|
33,437 |
|
||
| Other financing, net |
|
7,881 |
|
|
238 |
|
||
| Net cash provided by (used in) financing activities | $ |
3,358,602 |
|
$ |
41,687 |
|
||
| Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash |
|
581 |
|
|
25 |
|
||
| Net change in cash, cash equivalents and restricted cash |
|
980,908 |
|
|
18,759 |
|
||
| Cash, cash equivalents and restricted cash at the beginning of the period |
|
56,840 |
|
|
38,081 |
|
||
| Cash, cash equivalents and restricted cash at the end of the period | $ |
1,037,748 |
|
$ |
56,840 |
|
||
IonQ, Inc. Reconciliation of Non-GAAP Financial Measures (unaudited) (in thousands, except per share data) |
||||||||||||||||
| Net Loss to Adjusted EBITDA | ||||||||||||||||
Three Months Ended December 31, |
|
Year Ended December 31, |
||||||||||||||
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
||
| Net income (loss) attributable to IonQ, Inc. | $ |
753,667 |
|
$ |
(201,998 |
) |
$ |
(510,378 |
) |
$ |
(331,647 |
) |
||||
| Net income (loss) attributable to noncontrolling interests |
|
(394 |
) |
|
— |
|
|
(1,743 |
) |
|
— |
|
||||
| Interest income, net |
|
(29,528 |
) |
|
(4,141 |
) |
|
(55,997 |
) |
|
(18,249 |
) |
||||
| Interest expense |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
||||
| Income tax (benefit) expense |
|
(24,877 |
) |
|
20 |
|
|
(44,572 |
) |
|
59 |
|
||||
| Depreciation and amortization |
|
40,645 |
|
|
5,504 |
|
|
82,004 |
|
|
18,654 |
|
||||
| Stock-based compensation |
|
106,666 |
|
|
39,271 |
|
|
312,032 |
|
|
106,878 |
|
||||
| Executive cash based-severance |
|
2,026 |
|
|
— |
|
|
9,418 |
|
|
— |
|
||||
| (Gain) loss on change in fair value of warrant liabilities |
|
(949,640 |
) |
|
128,505 |
|
|
(66,710 |
) |
|
117,107 |
|
||||
| Offering costs associated with warrants |
|
22,867 |
|
|
— |
|
|
45,714 |
|
|
— |
|
||||
| Acquisition transaction and integration costs |
|
11,175 |
|
|
1,526 |
|
|
43,479 |
|
|
1,526 |
|
||||
| Adjusted EBITDA | $ |
(67,393 |
) |
$ |
(31,313 |
) |
$ |
(186,753 |
) |
$ |
(105,672 |
) |
||||
| Net Loss per Share to Adjusted EPS | ||||||||||||||||
Three Months Ended December 31, |
||||||||||||||||
2025 |
|
2024 |
||||||||||||||
Amount |
|
Per Share |
|
Amount |
|
Per Share |
||||||||||
| Net income (loss) per share attributable to IonQ, Inc. common stockholders | $ |
2.13 |
|
$ |
(0.93 |
) |
||||||||||
| Stock-based compensation | $ |
106,666 |
|
|
0.31 |
|
$ |
39,271 |
|
|
0.18 |
|
||||
| Executive cash-based severance |
|
2,026 |
|
|
0.01 |
|
|
— |
|
|
— |
|
||||
| (Gain) loss on change in fair value of warrant liabilities |
|
(949,640 |
) |
|
(2.75 |
) |
|
128,505 |
|
|
0.59 |
|
||||
| Offering costs associated with warrants |
|
22,867 |
|
|
0.07 |
|
|
— |
|
|
— |
|
||||
| Acquisition transaction and integration costs |
|
11,175 |
|
|
0.03 |
|
|
1,526 |
|
|
0.01 |
|
||||
| Adjusted EPS | $ |
(0.20 |
) |
$ |
(0.15 |
) |
||||||||||
Year Ended December 31, |
||||||||||||||||
2025 |
|
2024 |
||||||||||||||
Amount |
|
Per Share |
|
Amount |
|
Per Share |
||||||||||
| Net income (loss) per share attributable to IonQ, Inc. common stockholders | $ |
(1.82 |
) |
$ |
(1.56 |
) |
||||||||||
| Stock-based compensation | $ |
312,032 |
|
|
1.11 |
|
$ |
106,878 |
|
|
0.50 |
|
||||
| Executive cash-based severance |
|
9,418 |
|
|
0.03 |
|
|
— |
|
|
— |
|
||||
| (Gain) loss on change in fair value of warrant liabilities |
|
(66,710 |
) |
|
(0.24 |
) |
|
117,107 |
|
|
0.55 |
|
||||
| Offering costs associated with warrants |
|
45,714 |
|
|
0.16 |
|
|
— |
|
|
— |
|
||||
| Acquisition transaction and integration costs |
|
43,479 |
|
|
0.16 |
|
|
1,526 |
|
|
0.01 |
|
||||
| Adjusted EPS | $ |
(0.60 |
) |
$ |
(0.50 |
) |
||||||||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20260225290197/en/
IonQ Media contacts:
Cheryl Krauss
cheryl.krauss@ionq.co
Tor Constantino
tor.constantino@ionq.co
IonQ Investor Contact:
investors@ionq.com
Source: IonQ